Diabetic Foot Ulcers Treatment Market, By Product Type (Wound Care Dressings (Foam Dressing, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressing), Biologics (Growth factors, Skin Graft, and Skin Substitutes), Wound Care Therapy Devices (Negative Pressure Wound Devices, Hyperbaric Oxygen Therapy, and Other Wound Care Therapy Devices), and Others), By Ulcers Type (Neuropathic Ulcers and Neuro-Ischemic Ulcers), By Distribution Channel (Hospitals, Clinics, Ambulatory Surgical Center, and Homecare Setting), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI10318 | Publish Date: May 2024 | No. of Pages: 180

Global Diabetic Foot Ulcers Market Companies

  • Medtronic Plc
  • Coloplast A/S
  • Acelity L.P. Inc.
  • 3M Healthcare
  • Smith & Nephew Plc.
  • ConvaTecInc
  • B.BraunMelsungen AG
  • Mölnlycke Health Care

Recent News:

  • In October 2022, Healthium Medtech, announced the launched of “Theruptor Novo” line of dressings to treat chronic wounds, including diabetic foot ulcers. This strategy has helped the company expand its offering of advanced wound care products and meet the growing demand for wound care products.
  • In January 2022, Smith+Nephew received FDA clearance for the PICO 7 and PICO 14 disposable negative pressure wound therapy for the treatment of Type I and Type II wounds, including burns and traumatic foot ulcers injury, subacute, due to diabetes. This strategy has helped the company increase the accessibility of its products to a wide customer base.